Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079667908> ?p ?o ?g. }
- W2079667908 endingPage "1211" @default.
- W2079667908 startingPage "1206" @default.
- W2079667908 abstract "Chemical coupling of polyethylene glycol (PEG) to proteins or particles (PEGylation), prolongs their circulation half-life by greater than 50-fold, reduces their immunogenicity, and also promotes their accumulation in tumors due to enhanced permeability and retention effect. Herein, phase separation method was used to prepare bovine serum albumin (BSA) nanoparticles. PEGylation of BSA nanoparticles was performed by SPA activated mPEG through their free amino groups. Effect of process variables on PEGylation efficiency of BSA nanoparticles was investigated and optimized through response surface methodology with the amount of free amino groups as response. Optimum conditions was found to be 32.5 g/l of PEG concentration, PEG-nanoparticle incubation time of 10 min, incubation temperature of 27°C, and pH of 7 for 5 mg of BSA nanoparticles in 1 mL phosphate buffer. Analysis of data showed that PEG concentration had the most noticeable effect on the amount of PEGylated amino groups, but pH had the least. Mean diameter and zeta potential of PEGylated nanoparticles under these conditions were 217 nm and −14 mV, respectively. In conclusion, PEGylated nanoparticles demonstrated reduction of the negative surface charge compared to the non modified particles with the zeta potential of −31.7 mV. Drug release from PEGylated nanoparticles was almost slower than non-PEGylated ones, probably due to existence of a PEG layer around PEGylated particles which makes an extra resistance in opposition to drug diffusion." @default.
- W2079667908 created "2016-06-24" @default.
- W2079667908 creator A5001050458 @default.
- W2079667908 creator A5021522417 @default.
- W2079667908 creator A5054648725 @default.
- W2079667908 creator A5056174444 @default.
- W2079667908 date "2010-08-03" @default.
- W2079667908 modified "2023-10-17" @default.
- W2079667908 title "Optimization of PEGylation Conditions for BSA Nanoparticles Using Response Surface Methodology" @default.
- W2079667908 cites W1555291331 @default.
- W2079667908 cites W1597997684 @default.
- W2079667908 cites W1967618971 @default.
- W2079667908 cites W1970239046 @default.
- W2079667908 cites W1981904613 @default.
- W2079667908 cites W1982628018 @default.
- W2079667908 cites W1991031656 @default.
- W2079667908 cites W1998682612 @default.
- W2079667908 cites W2001107461 @default.
- W2079667908 cites W2002516695 @default.
- W2079667908 cites W2003945092 @default.
- W2079667908 cites W2008594853 @default.
- W2079667908 cites W2009119064 @default.
- W2079667908 cites W2011910815 @default.
- W2079667908 cites W2025017345 @default.
- W2079667908 cites W2027696154 @default.
- W2079667908 cites W2034633336 @default.
- W2079667908 cites W2037008627 @default.
- W2079667908 cites W2037048276 @default.
- W2079667908 cites W2050356627 @default.
- W2079667908 cites W2066119709 @default.
- W2079667908 cites W2068240430 @default.
- W2079667908 cites W2082885247 @default.
- W2079667908 cites W2085092548 @default.
- W2079667908 cites W2092652665 @default.
- W2079667908 cites W2118878458 @default.
- W2079667908 cites W2145017051 @default.
- W2079667908 cites W2156492800 @default.
- W2079667908 cites W2161580101 @default.
- W2079667908 cites W2334013252 @default.
- W2079667908 cites W2504219303 @default.
- W2079667908 cites W4236136784 @default.
- W2079667908 cites W4242601767 @default.
- W2079667908 doi "https://doi.org/10.1208/s12249-010-9487-8" @default.
- W2079667908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2974113" @default.
- W2079667908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20680708" @default.
- W2079667908 hasPublicationYear "2010" @default.
- W2079667908 type Work @default.
- W2079667908 sameAs 2079667908 @default.
- W2079667908 citedByCount "89" @default.
- W2079667908 countsByYear W20796679082012 @default.
- W2079667908 countsByYear W20796679082013 @default.
- W2079667908 countsByYear W20796679082014 @default.
- W2079667908 countsByYear W20796679082015 @default.
- W2079667908 countsByYear W20796679082016 @default.
- W2079667908 countsByYear W20796679082017 @default.
- W2079667908 countsByYear W20796679082018 @default.
- W2079667908 countsByYear W20796679082019 @default.
- W2079667908 countsByYear W20796679082020 @default.
- W2079667908 countsByYear W20796679082021 @default.
- W2079667908 countsByYear W20796679082022 @default.
- W2079667908 countsByYear W20796679082023 @default.
- W2079667908 crossrefType "journal-article" @default.
- W2079667908 hasAuthorship W2079667908A5001050458 @default.
- W2079667908 hasAuthorship W2079667908A5021522417 @default.
- W2079667908 hasAuthorship W2079667908A5054648725 @default.
- W2079667908 hasAuthorship W2079667908A5056174444 @default.
- W2079667908 hasBestOaLocation W20796679082 @default.
- W2079667908 hasConcept C10138342 @default.
- W2079667908 hasConcept C127413603 @default.
- W2079667908 hasConcept C155672457 @default.
- W2079667908 hasConcept C162324750 @default.
- W2079667908 hasConcept C171250308 @default.
- W2079667908 hasConcept C178790620 @default.
- W2079667908 hasConcept C185592680 @default.
- W2079667908 hasConcept C192562407 @default.
- W2079667908 hasConcept C2776964284 @default.
- W2079667908 hasConcept C2779149719 @default.
- W2079667908 hasConcept C42360764 @default.
- W2079667908 hasConcept C43617362 @default.
- W2079667908 hasConcept C54400483 @default.
- W2079667908 hasConcept C86181022 @default.
- W2079667908 hasConcept C86807702 @default.
- W2079667908 hasConceptScore W2079667908C10138342 @default.
- W2079667908 hasConceptScore W2079667908C127413603 @default.
- W2079667908 hasConceptScore W2079667908C155672457 @default.
- W2079667908 hasConceptScore W2079667908C162324750 @default.
- W2079667908 hasConceptScore W2079667908C171250308 @default.
- W2079667908 hasConceptScore W2079667908C178790620 @default.
- W2079667908 hasConceptScore W2079667908C185592680 @default.
- W2079667908 hasConceptScore W2079667908C192562407 @default.
- W2079667908 hasConceptScore W2079667908C2776964284 @default.
- W2079667908 hasConceptScore W2079667908C2779149719 @default.
- W2079667908 hasConceptScore W2079667908C42360764 @default.
- W2079667908 hasConceptScore W2079667908C43617362 @default.
- W2079667908 hasConceptScore W2079667908C54400483 @default.
- W2079667908 hasConceptScore W2079667908C86181022 @default.
- W2079667908 hasConceptScore W2079667908C86807702 @default.
- W2079667908 hasIssue "3" @default.